Possible cases: Amgen recalls certain lots of anemia drugs

 Amgen reminders anemia drugs Washington, DC: Amgen announced today that some batches of EPOGEN and PROCRIT (League Epoetin) vials are being voluntarily recalled specialist distributors, wholesalers, pharmacies and suppliers of health as a precautionary measure.

The product is being recalled may contain extremely thin glass glitter (MOP) who are barely visible in most cases.The strips are the result of interaction with glass on the life of the produit.Les bottles produced formulation for the treatment of anaemia related to therapy of HIV, chronic renal failure and chemotherapy are given.

Evaluations by Amgen and Centocor Ortho Biotech Products, L.P. has found a low potential for patients who may have received impact product potential concerné.Les serious adverse events resulting from using a sterile injectable product with particles intravenously include embolic, thrombotic and other vascular events (e.g., phlébite) and percutaneous include foreign body Granuloma of local injection site reactions, increased immunogenicity.

A list of numbers of consignment of the product concerned and expiration dates is available via the link below.

SEP-27-10: Amgen launches voluntary national recall of certain lots of Epogen and Procrit (Epoetin Alfa) [FDA: MEDWATCH]

If you or a loved one to suffered from disease or an adverse event on health resulting from the use of the any of the products concerned, please click on the link below and your complaint will be sent to a lawyer who can evaluate your request at no cost or obligation.